HUNTINGTON NATIONAL BANK - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68,148
+6.9%
1,784
+1.0%
0.00%0.0%
Q2 2023$63,733
+80.2%
1,767
+90.8%
0.00%
Q1 2023$35,364
-23.8%
926
+13.5%
0.00%
Q4 2022$46,430
+25.5%
816
-13.7%
0.00%
Q3 2022$37,000
+12.1%
946
+26.1%
0.00%
Q2 2022$33,000
+153.8%
750
+138.1%
0.00%
Q1 2022$13,0000.0%3150.0%0.00%
Q4 2021$13,000
+550.0%
315
+600.0%
0.00%
Q3 2021$2,000450.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 19,829,337$266,308,00010.60%
BB BIOTECH AG 6,929,832$93,068,0002.95%
SECTORAL ASSET MANAGEMENT INC 2,671,051$35,872,0001.64%
Sterling Global Strategies LLC 22,000$295,0001.63%
Lombard Odier Asset Management (USA) Corp 1,061,547$14,257,0001.24%
PYRRHO CAPITAL MANAGEMENT, LP 90,000$1,209,0001.04%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,184,003$109,911,0000.93%
Bellevue Asset Management AG 246,000$3,304,0000.54%
Convergence Investment Partners, LLC 251,748$3,381,0000.39%
Rhenman & Partners Asset Management AB 172,000$2,310,0000.37%
View complete list of HALOZYME THERAPEUTICS INC shareholders